|Articles|November 18, 2015
Michael J. Mauro Discusses the Diagnosis of CML
Author(s)Michael J. Mauro
Michael J. Mauro, leader, Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses the diagnosis of chronic myeloid leukemia (CML).
Advertisement
Michael J. Mauro, leader, Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses the diagnosis of chronic myeloid leukemia (CML).
Advertisement
Related Content
Advertisement
Advertisement
Trending on CURE
1
Diagnosed at 25 With Hodgkin's Lymphoma, She Says This Saved Her Life
2
Minimally Invasive Options in Rectal Cancer: TAMIS and Robotic Surgery
3
RASolute 302 and the Future of Pancreatic Cancer Treatment: Paul Oberstein, MD, on the KRAS Breakthrough
4
Why I Don’t Want to Hear “You’ll Beat This” After a Metastatic Breast Cancer Diagnosis
5